business
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
Key takeaways
- Livestream Menu Make Itselect USAINTLLivestream Search quotes, news & videos Livestream Watchlist SIGN INCreate free account Markets Business Investing Tech Politics Video Watchlist Investing Club PROLivestream Menu
- The day has finally come: we have the first-ever generic versions of Novo Nordisk's wildly popular diabetes drug Ozempic in North America.
- Health Canada approved the first one by Indian drugmaker Dr.
Livestream Menu Make Itselect USAINTLLivestream Search quotes, news & videos Livestream Watchlist SIGN INCreate free account Markets Business Investing Tech Politics Video Watchlist Investing Club PROLivestream Menu
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
The day has finally come: we have the first-ever generic versions of Novo Nordisk's wildly popular diabetes drug Ozempic in North America.
Article preview — originally published by CNBC. Full story at the source.
Read full story on CNBC →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from CNBC alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop